Skip to main content
SpringerLink
Log in

Kardiale Erkrankungen

  • Chapter
Neugeborenenintensivmedizin

  • 3059 Accesses

Zusammenfassung

Rund 6000 Kinder kommen jährlich in Deutschland mit angeborenem Herzfehler zur Welt. Dies entspricht einer Prävalenz von 1 % aller Neugeborenen, bei Frühgeborenen oder Mehrlingen ist sie jedoch doppelt so hoch [62, 108]. Ein Drittel der Kinder mit Herzfehler benötigt in der Neonatalperiode eine medikamentöse, katheterinterventionelle oder operative Behandlung [92]. Postnatal ist der Kreislauf erheblichen Umstellungsvorgängen unterworfen. Dadurch werden einige in utero gut tolerierte angeborene Herzfehler in den ersten Stunden nach der Geburt symptomatisch. Heute wird die Mehrzahl der komplexen Herzfehler pränatal diagnostiziert. Die Häufigkeit und Treffsicherheit der Pränataldiagnostik weist große regionale Unterschiede auf und ist von der Art des Herzfehlers abhängig. So wird z. B. die totale Lungenvenenfehlmündung oft nicht pränatal erkannt, da kaum Blut über die Lungenvenen fließt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 336(8):525–33

    Google Scholar 

  2. (1999) Systolic blood pressure in babies of less than 32 weeks gestation in the first year of life. Northern Neonatal Nursing Initiative. Arch Dis Child Fetal Neonatal Ed 80(1):F38–42

    Google Scholar 

  3. Ahlfors CE (2004) Effect of ibuprofen on bilirubin-albumin binding. J Pediatr 144(3):386–8

    PubMed  CAS  Google Scholar 

  4. Alwi M, Choo KK, Latiff HA, Kandavello G, Samion H, Mulyadi MD (2004) Initial results and medium-term follow-up of stent implantation of patent ductus arteriosus in duct-dependent pulmonary circulation. J Am Coll Cardiol 44(2):438–45

    PubMed  Google Scholar 

  5. Arlettaz R, Bauschatz AS, Monkhoff M, Essers B, Bauersfeld U (2006) The contribution of pulse oximetry to the early detection of congenital heart disease in newborns. Eur J Pediatr 165(2):94–8

    PubMed  Google Scholar 

  6. Bahrami KR, Van Meurs KP (2005) ECMO for neonatal respiratory failure. Semin Perinatol 29(1):15–23

    PubMed  Google Scholar 

  7. Bailey JM, Hoffman TM, Wessel DL, Nelson DP, Atz AM, Chang AC, Kulik TJ, Spray TL, Akbary A, Miller RP, Wernovsky G (2004) A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J Pharmacokinet Pharmacodyn 31(1):43–59

    PubMed  CAS  Google Scholar 

  8. Balaguru D, Auslender M (2000) Vasodilators in the treatment of pediatric heart failure. Prog Pediatr Cardiol 12(1):81–90

    PubMed  Google Scholar 

  9. Ballweg JA, Dominguez TE, Ravishankar C, Gaynor JW, Nicolson SC, Spray TL, Tabbutt S (2010) A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at Fontan completion. J Thorac Cardiovasc Surg 140(3):537–44

    PubMed  Google Scholar 

  10. Barrington KJ, Finer NN (2007) Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev (3):CD000509

    PubMed  Google Scholar 

  11. Bassler D, Choong K, McNamara P, Kirpalani H (2006) Neonatal persistent pulmonary hypertension treated with milrinone: four case reports. Biol Neonate 89(1):1–5

    PubMed  Google Scholar 

  12. Bell E, Acarregui M (2001) Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev (3):CD000503

    PubMed  Google Scholar 

  13. Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA (2003) Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42(3):466–72

    PubMed  Google Scholar 

  14. Brown JW, Park HJ, Turrentine MW (2001) Arterial switch operation: factors impacting survival in the current era. Ann Thorac Surg 71(6):1978–84

    PubMed  CAS  Google Scholar 

  15. Brown KL, Miles F, Sullivan ID, Hoskote A, Verhulst L, Ridout DA, Goldman AP (2005) Outcome in neonates with congenital heart disease referred for respiratory extracorporeal membrane oxygenation. Acta Paediatr 94(9):1280–4

    PubMed  Google Scholar 

  16. Buck ML (2005) Clinical experience with spironolactone in pediatrics. Ann Pharmacother 39(5):823–8

    PubMed  CAS  Google Scholar 

  17. Capomolla S, Febo O, Opasich C, Guazzotti G, Caporotondi A, La Rovere MT, Gnemmi M, Mortara A, Vona M, Pinna GD, Maestri R, Cobelli F (2001) Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome. Eur J Heart Fail 3(5):601–10

    PubMed  CAS  Google Scholar 

  18. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354(6):579–87

    PubMed  CAS  Google Scholar 

  19. Channer K, McLean KA, Lawson-Matthew P, Richardson M (1994) Combination diuretic treatment in severe heart failure: a randomised controlled trial. Br Heart J 71:146–50

    PubMed  CAS  Google Scholar 

  20. Cooke L, Steer P, Woodgate P (2003) Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev:CD003745

    Google Scholar 

  21. Cornfield DN, Maynard RC, deRegnier RA, Guiang SF 3rd, Barbato JE, Milla CE (1999) Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension. Pediatrics 104(5 Pt 1):1089–94

    PubMed  CAS  Google Scholar 

  22. Crochemore C, Lu J, Wu Y, Liposits Z, Sousa N, Holsboer F, Almeida OF (2005) Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol Psychiatry 10(8):790–8

    PubMed  CAS  Google Scholar 

  23. Crosson JE, Etheridge SP, Milstein S, Hesslein PS, Dunnigan A (1994) Therapeutic and diagnostic utility of adenosine during tachycardia evaluation in children. Am J Cardiol 74(2):155–60

    PubMed  CAS  Google Scholar 

  24. Dalton HJ, Rycus PT, Conrad SA (2005) Update on extracorporeal life support 2004. Semin Perinatol 29(1):24–33

    PubMed  Google Scholar 

  25. De Lagausie P, de Buys-Roessingh A, Ferkdadji L, Saada J, Aisenfisz S, Martinez-Vinson C, Fund X, Cayuela JM, Peuchmaur M, Mercier JC, Berrebi D (2005) Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia. J Pathol 205(1):112–8

    PubMed  Google Scholar 

  26. Deloof E, Devlieger H, Van Hoestenberghe R, Van den Berghe K, Daenen W, Gewillig M (1997) Management with a staged approach of the premature hydropic fetus due to complete congenital heart block. Eur J Pediatr 156(7):521–3

    PubMed  CAS  Google Scholar 

  27. Dorostkar PC, Arko MK, Baird TM, Rodriguez S, Martin RJ (2005) Asystole and severe bradycardia in preterm infants. Biol Neonate 88(4):299–305

    PubMed  Google Scholar 

  28. Duggal B, Pratap U, Slavik Z, Kaplanova J, Macrae D (2005) Milrinone and low cardiac output following cardiac surgery in infants: is there a direct myocardial effect? Pediatr Cardiol 26(5):642–5

    PubMed  CAS  Google Scholar 

  29. Duncan BW, Bohn DJ, Atz AM, French JW, Laussen PC, Wessel DL (2001) Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 122(3):440–8

    PubMed  CAS  Google Scholar 

  30. Etheridge SP, Craig JE, Compton SJ (2001) Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants. Am Heart J 141(1):105–10

    PubMed  CAS  Google Scholar 

  31. Evans N, Iyer P (1993) Change in blood pressure after treatment of patent ductus arteriosus with indomethacin. Arch Dis Child 68(5 Spec No):584–7

    PubMed  CAS  Google Scholar 

  32. Evans N, Kluckow M, Simmons M, Osborn D (2002) Which to measure, systemic or organ blood flow? Middle cerebral artery and superior vena cava flow in very preterm infants. Arch Dis Child Fetal Neonatal Ed 87(3):F181–4

    PubMed  CAS  Google Scholar 

  33. Evans N, Osborn D, Kluckow M (2005) Preterm circulatory support is more complex than just blood pressure. Pediatrics 115(4):1114–5; author reply 5–6

    PubMed  Google Scholar 

  34. Finer NN, Barrington KJ (2001) Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev (2):CD000399

    PubMed  Google Scholar 

  35. Finer NN, Barrington KJ (2006) Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev (4):CD000399

    PubMed  Google Scholar 

  36. Fowlie P, Davis P (2002) Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev (3):CD000174

    PubMed  Google Scholar 

  37. Garty Y, Veldtman G, Lee K, Benson L (2005) Late outcomes after pulmonary valve balloon dilatation in neonates, infants and children. J Invasive Cardiol 17(6):318–22

    PubMed  Google Scholar 

  38. Glass P, Wagner AE, Papero PH, Rajasingham SR, Civitello LA, Kjaer MS, Coffman CE, Getson PR, Short BL (1995) Neurodevelopmental status at age five years of neonates treated with extracorporeal membrane oxygenation. J Pediatr 127(3):447–57

    PubMed  CAS  Google Scholar 

  39. Glen S, Burns J, Bloomfield P (2004) Prevalence and development of additional cardiac abnormalities in 1448 patients with congenital ventricular septal defects. Heart 90(11):1321–5

    PubMed  CAS  Google Scholar 

  40. Goldberg CS, Gomez CA (2003) Hypoplastic left heart syndrome: new developments and current controversies. Semin Neonatol 8(6):461–8

    PubMed  Google Scholar 

  41. Goldmuntz E (2005) DiGeorge syndrome: new insights. Clin Perinatol 32(4):963–78, ix-x

    PubMed  Google Scholar 

  42. Habib DM, Padbury JF, Anas NG, Perkin RM, Minegar C (1992) Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients. Crit Care Med 20(5):601–8

    PubMed  CAS  Google Scholar 

  43. Hardart GE, Hardart MK, Arnold JH (2004) Intracranial hemorrhage in premature neonates treated with extracorporeal membrane oxygenation correlates with conceptional age. J Pediatr 145(2):184–9

    PubMed  Google Scholar 

  44. Hausdorf G (2000) Intensivtherapie angeborener Herzfehler. Steinkopff, Darmstadt

    Google Scholar 

  45. Hawkins JA, Minich LL, Tani LY, Day RW, Judd VE, Shaddy RE, McGough EC (1998) Late results and reintervention after aortic valvotomy for critical aortic stenosis in neonates and infants. Ann Thorac Surg 65(6):1758–62; discussion 63

    PubMed  CAS  Google Scholar 

  46. Hebra A, Brown MF, Hirschl RB, McGeehin K, O‘Neill JA Jr, Norwood WI, Ross AJ 3rd (1993) Mesenteric ischemia in hypoplastic left heart syndrome. J Pediatr Surg 28(4):606–11

    PubMed  CAS  Google Scholar 

  47. Herrera C, Holberton J, Davis P (2007) Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (2):CD003480

    PubMed  Google Scholar 

  48. Hoffman GM, Ross GA, Day SE, Rice TB, Nelin LD (1997) Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn. Crit Care Med 25(2):352–9

    PubMed  CAS  Google Scholar 

  49. Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, Bailey JM, Akbary A, Kocsis JF, Kaczmarek R, Spray TL, Wessel DL (2003) Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107(7):996–1002

    PubMed  CAS  Google Scholar 

  50. Howard LS, Morrell NW (2005) New therapeutic agents for pulmonary vascular disease. Paediatr Respir Rev 6(4):285–91

    PubMed  Google Scholar 

  51. Iyer P, Evans N (1994) Re-evaluation of the left atrial to aortic root ratio as a marker of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 70(2):F112–7

    PubMed  CAS  Google Scholar 

  52. Juliana AE, Abbad FC (2005) Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil. Eur J Pediatr 164(10):626–9

    PubMed  Google Scholar 

  53. Kearin M, Kelly JG, O‘Malley K (1980) Digoxin »receptors« in neonates: an explanation of less sensitivity to digoxin than in adults. Clin Pharmacol Ther 28:346–9

    PubMed  CAS  Google Scholar 

  54. Kinsella JP, Abman SH (1997) Inhaled nitric oxide in the premature infant: animal models and clinical experience. Semin Perinatol 21(5):418–25

    PubMed  CAS  Google Scholar 

  55. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, deLemos RA, Sardesai S, McCurnin DC, Moreland SG, Cutter GR, Abman SH (1997) Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 131(1 Pt 1):55–62

    PubMed  CAS  Google Scholar 

  56. Kluckow M, Evans N (1995) Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 127(5):774–9

    PubMed  CAS  Google Scholar 

  57. Koehne P, Rüdiger M (2005) Persistierender Ductus arteriosus des Frühgeborenen. In: Bassler D, Forster J, Antes G (Hrsg) Evidenz-basierte Pädiatrie, Ergänzungswerk 1. Thieme, Stuttgart, S 1–28

    Google Scholar 

  58. Kostelka M, Walther T, Geerdts I, Rastan A, Jacobs S, Dahnert I, Kiefer H, Bellinghausen W, Mohr FW (2004) Primary repair for aortic arch obstruction associated with ventricular septal defect. Ann Thorac Surg 78(6):1989–93; discussion 93

    PubMed  Google Scholar 

  59. Latifi S, Lidsky K, Blumer JL (2000) Pharmacology of inotropic agents in infants and children. Prog Pediatr Cardiol 12(1):57–79

    PubMed  Google Scholar 

  60. Lewis A, Freed M, Heymann M, Roehl S, Kinsey R (1981) Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 64:893–8

    PubMed  CAS  Google Scholar 

  61. Lin HC, Su BH, Lin TW, Tsai CH, Yeh TF (2005) System-based strategy for the management of meconium aspiration syndrome: 198 consecutive cases observations. Acta Paediatr Taiwan 46(2):67–71

    PubMed  Google Scholar 

  62. Lindinger A, Schwedler G, Hense HW (2010) Prevalence of Congenital Heart Defects in Newborns in Germany: Results of the First Registration Year of the PA N Study (July 2006 to June 2007). Klin Padiatr 222(5):321–6

    PubMed  CAS  Google Scholar 

  63. Long W (1990) Fetal and neonatal cardiology. Saunders, Philadelphia

    Google Scholar 

  64. Luciani GB, Nichani S, Chang AC, Wells WJ, Newth CJ, Starnes VA (1997) Continuous versus intermittent furosemide infusion in critically ill infants after open heart operations. Ann Thorac Surg 64(4):1133–9

    PubMed  CAS  Google Scholar 

  65. Mahle WT, Spray TL, Wernovsky G, Gaynor JW, Clark BJ 3rd (2000) Survival after reconstructive surgery for hypoplastic left heart syndrome: A 15-year experience from a single institution. Circulation 102(19 Suppl 3):II136–41

    Google Scholar 

  66. Malviya M, Ohlsson A, Shah S (2003) Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (3):CD003951

    PubMed  Google Scholar 

  67. Marmon LM, Bye MR, Haas JM, Balsara RK, Dunn JM (1984) Vascular rings and slings: long-term follow-up of pulmonary function. J Pediatr Surg 19(6):683–92

    PubMed  CAS  Google Scholar 

  68. McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342(10):690–5

    PubMed  Google Scholar 

  69. McCrindle BW (2005) Is balloon aortic valvuloplasty a feasible treatment for neonates and young infants with aortic valve stenosis? Nat Clin Pract Cardiovasc Med 2(7):340–1

    PubMed  Google Scholar 

  70. McElhinney DB, Hedrick HL, Bush DM, Pereira GR, Stafford PW, Gaynor JW, Spray TL, Wernovsky G (2000) Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes. Pediatrics 106(5):1080–7

    PubMed  CAS  Google Scholar 

  71. Michalsky MP, Arca MJ, Groenman F, Hammond S, Tibboel D, Caniano DA (2005) Alveolar capillary dysplasia: a logical approach to a fatal disease. J Pediatr Surg 40(7):1100–5

    PubMed  Google Scholar 

  72. Mirochnick MH, Miceli JJ, Kramer PA, Chapron DJ, Raye JR (1988) Furosemide pharmacokinetics in very low birth weight infants. J Pediatr 112(4):653–7

    PubMed  CAS  Google Scholar 

  73. Mugford M, Elbourne D, Field D (2008) Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database Syst Rev (3):CD001340

    PubMed  Google Scholar 

  74. Munro MJ, Walker AM, Barfield CP (2004) Hypotensive extremely low birth weight infants have reduced cerebral blood flow. Pediatrics 114(6):1591–6

    PubMed  Google Scholar 

  75. Neches W, Park S, Ettedgui J (1997) Tetralogy of Fallot and tetralogy of Fallot with pulmonary atresia. In: Garson A, Bricker JT, Fisher D, Neish S (Hrsg) The science and practice of pediatric cardiology. Lippincott Williams & Wilkins, Baltimore, S 1400

    Google Scholar 

  76. Obladen M, Koehne B (2004) Interventions for persisting Ductus arteriosus in the preterm infant. Springer, Heidelberg

    Google Scholar 

  77. Ohye RG, Gomez CA, Ohye BJ, Goldberg CS, Bove EL (2001) The Ross/Konno procedure in neonates and infants: intermediate-term survival and autograft function. Ann Thorac Surg 72(3):823–30

    PubMed  CAS  Google Scholar 

  78. Ohye RG, Sleeper LA, Mahony L, Newburger JW, Pearson GD, Lu M, Goldberg CS, Tabbutt S, Frommelt PC, Ghanayem NS, Laussen PC, Rhodes JF, Lewis AB, Mital S, Ravishankar C, Williams IA, Dunbar-Masterson C, Atz AM, Colan S, Minich LL, Pizarro C, Kanter KR, Jaggers J, Jacobs JP, Krawczeski CD, Pike N, McCrindle BW, Virzi L, Gaynor JW (2010) Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 362(21):1980–92

    PubMed  CAS  Google Scholar 

  79. Osborn DA, Evans N (2004) Early volume expansion for prevention of morbidity and mortality in very preterm infants. Cochrane Database Syst Rev (2):CD002055

    PubMed  Google Scholar 

  80. Paradisis M, Osborn DA (2004) Adrenaline for prevention of morbidity and mortality in preterm infants with cardiovascular compromise. Cochrane Database Syst Rev (1):CD003958

    PubMed  Google Scholar 

  81. Park Y, Lucas VW, Sklansky MS, Kashani IA, Rothman A (1997) Balloon angioplasty of native aortic coarctation in infants 3 months of age and younger. Am Heart J 134(5 Pt 1):917–23

    PubMed  CAS  Google Scholar 

  82. Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE (2004) Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol 44(3):513–9

    PubMed  Google Scholar 

  83. Paul T, Pfammatter JP (1997) Adenosine: an effective and safe antiarrhythmic drug in pediatrics. Pediatr Cardiol 18(2):118–26

    PubMed  CAS  Google Scholar 

  84. Paul T, Bertram H, Kriebel T, Windhagen-Mahnert B, Tebbenjohanns J, Hausdorf G (2000) Supraventrikuläre Tachykardien bei Säuglingen, Kindern und Jugendlichen: Diagnostik, medikamentöse und interventionelle Therapie. Z Kardiol 89:546–58

    PubMed  CAS  Google Scholar 

  85. Pellicer A, Valverde E, Elorza MD, Madero R, Gaya F, Quero J, Cabanas F (2005) Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial. Pediatrics 115(6):1501–12

    PubMed  Google Scholar 

  86. Pfammatter JP, Stocker FP (1998) Results of a restrictive use of antiarrhythmic drugs in the chronic treatment of atrioventricular reentrant tachycardias in infancy and childhood. Am J Cardiol 82(1):72–5

    PubMed  CAS  Google Scholar 

  87. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341(10):709–17

    PubMed  CAS  Google Scholar 

  88. Reynolds EW, Ellington JG, Vranicar M, Bada HS (2004) Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics 114(5):1297–304

    PubMed  Google Scholar 

  89. Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M (2001) Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms. Circulation 103(4):544–8

    PubMed  CAS  Google Scholar 

  90. Roberts JD Jr., Fineman JR, Morin FC 3rd, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol WM (1997) Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N Engl J Med 336(9):605–10

    PubMed  CAS  Google Scholar 

  91. Rosati E, Chitano G, Dipaola L, De Felice C, Latini G (2005) Indications and limitations for a neonatal pulse oximetry screening of critical congenital heart disease. J Perinat Med 33(5):455–7

    PubMed  Google Scholar 

  92. Roy DL, McIntyre L, Human DG, Nanton MA, Sherman GJ, Allen LM, Finley JP (1994) Trends in the prevalence of congenital heart disease: comprehensive observations over a 24-year period in a defined region of Canada. Can J Cardiol 10(8):821–6

    PubMed  CAS  Google Scholar 

  93. Sadiq HF, Mantych G, Benawra RS, Devaskar UP, Hocker JR (2003) Inhaled nitric oxide in the treatment of moderate persistent pulmonary hypertension of the newborn: a randomized controlled, multicenter trial. J Perinatol 23(2):98–103

    PubMed  CAS  Google Scholar 

  94. Saul JP, Walsh EP, Triedman JK (1995) Mechanisms and therapy of complex arrhythmias in pediatric patients. J Cardiovasc Electrophysiol 6(12):1129–48

    PubMed  CAS  Google Scholar 

  95. Shah PS, Ohlsson A (2007) Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev (3):CD005494

    PubMed  Google Scholar 

  96. Shah S, Ohlsson A (2006) Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev (1):CD004213

    PubMed  Google Scholar 

  97. Shann F (2008) Drug Doses. 14. Aufl. Royal Children‘s Hospital, Parkville Australia

    Google Scholar 

  98. Shinkawa T, Bove EL, Hirsch JC, Devaney EJ, Ohye RG (2010) Intermediate-term results of the Ross procedure in neonates and infants. Ann Thorac Surg 89(6):1827–32; discussion 32

    PubMed  Google Scholar 

  99. Simons SH, van Dijk M, van Lingen RA, Roofthooft D, Boomsma F, Van Den Anker JN, Tibboel D (2005) Randomised controlled trial evaluating effects of morphine on plasma adrenaline/noradrenaline concentrations in newborns. Arch Dis Child Fetal Neonatal Ed 90(1):F36–40

    PubMed  CAS  Google Scholar 

  100. Skinner J, Alverson D, Hunter S (2000) Echocardiography for the neonatologist, Churchill Livingstone Elsevier, Philadelphia

    Google Scholar 

  101. Spillers J (2010) PPHN: is sildenafil the new nitric? A review of the literature. Adv Neonatal Care 10(2):69–74

    PubMed  Google Scholar 

  102. Steinhorn RH, Cox PN, Fineman JR, Finer NN, Rosenberg EM, Silver MM, Tyebkhan J, Zwass MS, Morin FC 3rd (1997) Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J Pediatr 130(3):417–22

    PubMed  CAS  Google Scholar 

  103. Stiller B, Dähnert I, Weng Y, Hennig E, Hetzer R, Lange P (1999) Children may survive severe myocarditis with prolonged use of biventricular assist devices. Heart 82:237–40

    PubMed  CAS  Google Scholar 

  104. Stiller B, Hetzer R, Weng Y, Hummel M, Hennig E, Nagdyman N, Ewert P, Lehmkuhl H, Lange P (2003) Heart transplantation in children after mechanical circulatory support with pulsatile pneumatic assist device. J Heart Lung Transplant 22:1201–8

    PubMed  Google Scholar 

  105. Stiller B, Lemmer J, Merkle F, Alexi-Meskishvili V, Weng Y, Hübler M, Koster A, Drews T, Lange P, Hetzer R (2004) Consumption of blood products during mechanical circulatory support in children: comparison between ECMO and a pulsatile ventricular assist device. Intensive Care Med 30:1814–20

    PubMed  Google Scholar 

  106. Stiller B, Weng Y, Hubler M, Lemmer J, Nagdyman N, Redlin M, Lange P, Hetzer R (2005) Pneumatic pulsatile ventricular assist devices in children under 1 year of age. Eur J Cardiothorac Surg 28(2):234–9

    PubMed  Google Scholar 

  107. Subhedar NV, Shaw NJ (2003) Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev (3):CD001242

    PubMed  Google Scholar 

  108. Tanner K, Sabrine N, Wren C (2005) Cardiovascular malformations among preterm infants. Pediatrics 116(6):e833–8

    PubMed  Google Scholar 

  109. Thompson RB, Van Den Bos EJ, Esposito DJ, Owen CH, Glower DD (2003) The effects of acute afterload change on systolic ventricular function in conscious dogs with normal vs. failing hearts. Eur J Heart Fail 5(6):741–9

    PubMed  Google Scholar 

  110. Tibballs J, Chow CW (2002) Incidence of alveolar capillary dysplasia in severe idiopathic persistent pulmonary hypertension of the newborn. J Paediatr Child Health 38(4):397–400

    PubMed  CAS  Google Scholar 

  111. Tobler D, Williams WG, Jegatheeswaran A, Van Arsdell GS, McCrindle BW, Greutmann M, Oechslin EN, Silversides CK (2010) Cardiac outcomes in young adult survivors of the arterial switch operation for transposition of the great arteries. J Am Coll Cardiol 56(1):58–64

    PubMed  Google Scholar 

  112. Travadi JN, Patole SK (2003) Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review. Pediatr Pulmonol 36(6):529–35

    PubMed  CAS  Google Scholar 

  113. Ward K, Mullins C (1997) Anomalous pulmonary venous connections, vein stenosis, and atresia of the common vein. In: Garson A, Bricker JT, Fisher D, Neish S (Hrsg) The science and practice of pediatric cardiology. Williams & Wilkins, Baltimore, S 1431–45

    Google Scholar 

  114. Wedgwood S, Black SM (2005) Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 288(3):L480–7

    PubMed  CAS  Google Scholar 

  115. Weinberger B, Weiss K, Heck DE, Laskin DL, Laskin JD (2001) Pharmacologic therapy of persistent pulmonary hypertension of the newborn. Pharmacol Ther 89(1):67–79

    PubMed  CAS  Google Scholar 

  116. Wernovsky G, Ghanayem N, Ohye RG, Bacha EA, Jacobs JP, Gaynor JW, Tabbutt S (2007) Hypoplastic left heart syndrome: consensus and controversies in 2007. Cardiol Young 17(Suppl 2):75–86

    PubMed  Google Scholar 

  117. Wetter J, Belli E, Sinzobahamvya N, Blaschzok HC, Brecher AM, Urban AE (2001) Transposition of the great arteries associated with ventricular septal defect: surgical results and long-term outcome. Eur J Cardiothorac Surg 20(4):816–23

    PubMed  CAS  Google Scholar 

  118. Wood AE, Javadpour H, Duff D, Oslizlok P, Walsh K (2004) Is extended arch aortoplasty the operation of choice for infant aortic coarctation? Results of 15 years‘ experience in 181 patients. Ann Thorac Surg 77(4):1353–7; discussion 7–8

    PubMed  Google Scholar 

  119. Northern Neonatal Nursing Initiative (1999) Systolic blood pressure in babies of less than 32 weeks gestation in the first year of life. Arch Dis Child Fetal Neonatal Ed 80:F38–42

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für angeborene Herzfehler/Pädiatrische Kardiologie Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Freiburg, Mathildenstraße 1, 79106, Freiburg

    Prof. Dr. med. Brigitte Stiller (Direktorin)

Authors
  1. Prof. Dr. med. Brigitte Stiller
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Gießen und Marburg GmbH Standort Marburg, Baldinger Strasse, 35033, Marburg

    Rolf F. Maier (Direktor) (Direktor)

  2. Klinik für Neonatologie, Charité Virchow-Klinikum, Augustenburger Platz 1, 13353, Berlin

    Michael Obladen (em. Direktor) (em. Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Stiller, B. (2011). Kardiale Erkrankungen. In: Maier, R.F., Obladen, M. (eds) Neugeborenenintensivmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-01069-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-01069-9_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-01068-2

  • Online ISBN: 978-3-642-01069-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation